Joe Gordon, President, Global Consumer, Surgical and Vision Care at Bausch + Lomb, a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world, shares his unique point of view on the industry, Bausch & Lomb’s recent IPO, the upcoming innovation pipeline, and what he’s excited about in this next chapter of the company.
Joseph Gordon has more than two decades of experience in the consumer health care industry where he has held various leadership positions of increasing responsibility.
He first joined Bausch + Lomb in 2011, serving as Vice President, Global Sales and Marketing, for the company’s over-the-counter business, until it was acquired by Bausch Health in 2013. Immediately after that, as part of Bausch Health, Mr. Gordon was U.S. President, Consumer Health Care and Vision Care, Bausch + Lomb. During that time he led the Bausch + Lomb Consumer Health Care business to achieve industry-leading growth for six consecutive years and the Bausch + Lomb ULTRA ® and Biotrue ® ONEday contact lens brands to be the fastest-growing in their respective segments. Mr. Gordon most recently served as President & Co-Head, Bausch + Lomb/International at Bausch Health from 2018 to 2022.
Previously, Mr. Gordon led large sales and marketing organizations at Wyeth and Pfizer with responsibility for brands that included Advil and Centrum.
Mr. Gordon has a Bachelor of Science in Economics from Rutgers University.